Weekly Digest – October 2024 Weekly Digest – October 2024 30 Sep 2024: Alphamab Oncology and CSPC enter licensing agreement for Anti-HER2 bispecific ADC JSKN003 Alphamab Oncology announced a licensing agreement for the anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 with […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id